| 1 | Salivary Gland Neoplasms | 51.6% |
| 2 | Parotid Neoplasms | 41.1% |
| 3 | Leukoplakia, Oral | 34.4% |
| 4 | Facial Hemiatrophy | 33.5% |
| 5 | Melkersson-Rosenthal Syndrome | 33.5% |
| 6 | Glossitis | 33.1% |
| 7 | Macroglossia | 33.1% |
| 8 | Glossoptosis | 33.1% |
| 9 | Burning Mouth Syndrome | 30.3% |
| 10 | Lip Diseases | 30.3% |
| 11 | Oral Submucous Fibrosis | 30.3% |
| 12 | Periodontal Diseases | 30.3% |
| 13 | Salivary Gland Diseases | 30.3% |
| 14 | Stomatitis | 30.3% |
| 15 | Oral Ulcer | 30.3% |
| 16 | Palatal Neoplasms | 30% |
| 17 | Bell Palsy | 28.7% |
| 18 | Mouth Abnormalities | 27.1% |
| 19 | Salivary Gland Fistula | 26.4% |
| 20 | Glossitis, Benign Migratory | 24.6% |
| 21 | Facial Nerve Diseases | 24.5% |
| 22 | Granulomatosis, Orofacial | 24.5% |
| 23 | Oral candidiasis | 24.2% |
| 24 | Oral Fistula | 24.2% |
| 25 | Tooth Loss | 24.2% |
| 26 | Lichen Planus, Oral | 23.9% |
| 27 | Gingival Recession | 23.5% |
| 28 | Parotitis | 23.5% |
| 29 | Gingival Atrophy | 23.5% |
| 30 | Gingival Hemorrhage | 23% |
| 31 | Facial paralysis | 20% |
| 32 | Facial Paresis | 20% |
| 33 | Cheilitis | 19.8% |
| 34 | Drooling | 19.8% |
| 35 | Gingival Diseases | 19.8% |
| 36 | Periodontitis | 19.8% |
| 37 | Sialadenitis | 19.8% |
| 38 | Sialometaplasia, Necrotizing | 19.8% |
| 39 | Sialorrhea | 19.8% |
| 40 | Aphthous Stomatitis | 19.8% |
| 41 | Xerostomia | 19.8% |
| 42 | Hemifacial Spasm | 19.8% |
| 43 | Peri-Implantitis | 19.8% |
| 44 | Macrostomia | 17.6% |
| 45 | Microstomia | 17.6% |
| 46 | Tooth Diseases | 17.4% |
| 47 | Facial Neuralgia | 15.9% |
| 48 | Dental Fistula | 15.8% |
| 49 | Oroantral Fistula | 15.8% |
| 50 | Microglossia | 15.1% |
| 51 | Tongue Diseases | 15.1% |
| 52 | Gingivitis | 14.8% |
| 53 | Pericoronitis | 14.8% |
| 54 | Aggressive Periodontitis | 14.8% |
| 55 | Gingival Overgrowth | 14.8% |
| 56 | Parathyroid Neoplasms | 14.5% |
| 57 | Thyroid Neoplasm | 14.5% |
| 58 | Thyroid carcinoma | 14.5% |
| 59 | Giant Cell Epulis | 14.4% |
| 60 | Jaw Diseases | 14.4% |
| 61 | Pharyngeal Diseases | 14.4% |
| 62 | Vesicular Stomatitis | 13.6% |
| 63 | Behcet Syndrome | 13.3% |
| 64 | Tongue Neoplasms | 13.2% |
| 65 | Radicular Cyst | 13.1% |
| 66 | Tracheal Neoplasms | 13% |
| 67 | Pharyngeal Neoplasms | 12.6% |
| 68 | Abdominal Neoplasms | 12.6% |
| 69 | Soft Tissue Neoplasms | 12.6% |
| 70 | Thoracic Neoplasms | 12.6% |
| 71 | Cleft Palate | 12.5% |
| 72 | Gingival Hyperplasia | 12.2% |
| 73 | Gingival Hypertrophy | 12.2% |
| 74 | Mouth Neoplasms | 12.1% |
| 75 | Alveolar Bone Loss | 11.8% |
| 76 | Trigeminal Nerve Disorder | 11.8% |
| 77 | Mobius Syndrome | 11.5% |
| 78 | Herpes Zoster Oticus | 11.4% |
| 79 | Herpes Labialis | 11.2% |
| 80 | Esophageal Neoplasms | 11.2% |
| 81 | Temporomandibular Joint Disorders | 11.1% |
| 82 | Digestive System Neoplasms | 10.5% |
| 83 | Endocrine Gland Neoplasms | 10.5% |
| 84 | Eye Neoplasms | 10.5% |
| 85 | Nervous System Neoplasms | 10.5% |
| 86 | Bone neoplasms | 10.2% |
| 87 | Skin Neoplasms | 10.2% |
| 88 | Hematologic Neoplasms | 10.2% |
| 89 | Bruxism | 10.1% |
| 90 | Dental Leakage | 10.1% |
| 91 | Hypercementosis | 10.1% |
| 92 | Malocclusion | 10.1% |
| 93 | Tooth Crowding | 10.1% |
| 94 | Tooth Discoloration | 10.1% |
| 95 | Tooth Demineralization | 10.1% |
| 96 | Tooth Ankylosis | 10.1% |
| 97 | Splenic Neoplasms | 10.1% |
| 98 | Facial Nerve Injuries | 9.9% |
| 99 | Mumps | 9.7% |
| 100 | Trigeminal Neuralgia | 9.7% |
| 101 | Nasopharyngeal Neoplasms | 9.7% |
| 102 | Thyroid Nodule | 9.4% |
| 103 | Dental Enamel Hypoplasia | 8.8% |
| 104 | Hypodontia | 8.8% |
| 105 | Hypopharyngeal Neoplasms | 8.7% |
| 106 | Hypopharyngeal Cancer | 8.7% |
| 107 | Toxic Epidermal Necrolysis | 8.7% |
| 108 | Peritoneal Neoplasms | 8.7% |
| 109 | Stevens-Johnson Syndrome | 8.7% |
| 110 | Tooth Injuries | 8.4% |
| 111 | Ulcerative stomatitis | 8.2% |
| 112 | Maxillary Diseases | 8.2% |
| 113 | Tooth Resorption | 8.2% |
| 114 | Multiple Endocrine Neoplasia | 8.1% |
| 115 | Toothache | 8% |
| 116 | Paraneoplastic Encephalomyelitis | 7.9% |
| 117 | Ear Neoplasms | 7.9% |
| 118 | Eyelid Neoplasms | 7.9% |
| 119 | Hamartoma | 7.8% |
| 120 | Neoplasms, Hormone-Dependent | 7.8% |
| 121 | Neoplasms, Multiple Primary | 7.8% |
| 122 | Paraneoplastic Syndromes | 7.8% |
| 123 | Precancerous Conditions | 7.8% |
| 124 | Neoplasms, Second Primary | 7.8% |
| 125 | Mammary Neoplasms, Experimental | 7.8% |
| 126 | Pancreatic Neoplasm | 7.7% |
| 127 | Retroperitoneal Neoplasms | 7.4% |
| 128 | Jaw Abnormalities | 7.4% |
| 129 | Nasopharyngeal carcinoma | 7.4% |
| 130 | Acanthoma | 7.2% |
| 131 | Retrognathia | 7.2% |
| 132 | Pharyngitis | 6.9% |
| 133 | Tonsillar Neoplasms | 6.8% |
| 134 | Nose Neoplasms | 6.8% |
| 135 | Nasopharyngitis | 6.6% |
| 136 | Dental caries | 6.6% |
| 137 | Dental Plaque | 6.6% |
| 138 | Dental Pulp Calcification | 6.6% |
| 139 | Pulpitis | 6.6% |
| 140 | Tooth Erosion | 6.6% |
| 141 | Sicca Syndrome | 6.6% |
| 142 | Sjogren's Syndrome | 6.6% |
| 143 | Prognathism | 6.5% |
| 144 | Cyst | 6.3% |
| 145 | Neoplastic Processes | 6.3% |
| 146 | Neoplastic Syndromes, Hereditary | 6.3% |
| 147 | Pregnancy Complications, Neoplastic | 6.3% |
| 148 | Temporomandibular Joint Dysfunction Syndrome | 6.2% |
| 149 | Neoplasms, Experimental | 6.2% |
| 150 | Central Nervous System Neoplasms | 6% |
| 151 | Vascular Neoplasms | 6% |
| 152 | Thymus Neoplasms | 6% |
| 153 | Laryngeal neoplasm | 6% |
| 154 | Genital Neoplasms, Female | 6% |
| 155 | Breast Neoplasms, Male | 5.9% |
| 156 | Triple Negative Breast Neoplasms | 5.9% |
| 157 | Carcinoma, Lobular | 5.8% |
| 158 | Maxillofacial Abnormalities | 5.7% |
| 159 | Testicular Neoplasms | 5.6% |
| 160 | Tooth Avulsion | 5.4% |
| 161 | Dental Pulp Necrosis | 5.3% |
| 162 | Neoplasms, Radiation-Induced | 5.2% |
| 163 | Adrenal Gland Neoplasms | 5.1% |
| 164 | Gastrointestinal Neoplasms | 5.1% |
| 165 | Genital Neoplasms, Male | 5.1% |
| 166 | Liver neoplasms | 5.1% |
| 167 | Uveal Neoplasms | 5.1% |
| 168 | Micrognathism | 5.1% |
| 169 | Pierre Robin Syndrome | 5.1% |
| 170 | Urologic Neoplasms | 5% |
| 171 | Sebaceous Gland Neoplasms | 5% |
| 172 | Spinal Neoplasms | 5% |
| 173 | Bone Marrow Neoplasms | 5% |
| 174 | Thymoma | 4.9% |
| 175 | Multiple Endocrine Neoplasia Type 1 | 4.9% |
| 176 | Meningioma | 4.9% |
| 177 | Carcinoma, Pancreatic Ductal | 4.8% |
| 178 | Carcinoma 256, Walker | 4.7% |
| 179 | Carcinoma, Ehrlich Tumor | 4.7% |
| 180 | Dermoid Cyst | 4.7% |
| 181 | Carcinoma, Lewis Lung | 4.7% |
| 182 | Liver Neoplasms, Experimental | 4.6% |
| 183 | Trophoblastic Neoplasms | 4.5% |
| 184 | Leukemia, Experimental | 4.4% |
| 185 | Tonsillitis | 4.4% |
| 186 | Sleep Bruxism | 4.4% |
| 187 | Lemierre Syndrome | 4.4% |
| 188 | Basal Cell Nevus Syndrome | 4.2% |
| 189 | Paraneoplastic Cerebellar Degeneration | 4.2% |
| 190 | Tuberous Sclerosis | 4.2% |
| 191 | Erythroplasia | 4.2% |
| 192 | Follicular cyst | 4.2% |
| 193 | leukemia | 4.2% |
| 194 | Mucocele | 4.2% |
| 195 | Neoplasms, Germ Cell and Embryonal | 4.2% |
| 196 | Neoplasms, Glandular and Epithelial | 4.2% |
| 197 | Pilonidal Cyst | 4.2% |
| 198 | Thyroglossal Cyst | 4.2% |
| 199 | Synovial Cyst | 4.2% |
| 200 | Germ Cell Cancer | 4.2% |
| 201 | Aberrant Crypt Foci | 4.2% |
| 202 | Neuroectodermal Tumors | 4% |
| 203 | Meningeal Neoplasms | 3.9% |
| 204 | Melanoma, Experimental | 3.9% |
| 205 | Acoustic Neuroma | 3.9% |
| 206 | Sarcoma, Experimental | 3.9% |
| 207 | Leukemia, Radiation-Induced | 3.8% |
| 208 | Neoplasms, Neuroepithelial | 3.8% |
| 209 | Gliomatosis cerebri | 3.8% |
| 210 | Retropharyngeal Abscess | 3.8% |
| 211 | insulinoma | 3.8% |
| 212 | Hepatocellular Adenoma | 3.8% |
| 213 | ovarian neoplasm | 3.7% |
| 214 | Nephroblastoma | 3.7% |
| 215 | Vipoma | 3.7% |
| 216 | Pituitary Adenoma | 3.7% |
| 217 | Pituitary Neoplasms | 3.7% |
| 218 | Limbic Encephalitis | 3.7% |
| 219 | Gastrinoma | 3.7% |
| 220 | Glucagonoma | 3.7% |
| 221 | Retinoblastoma | 3.6% |
| 222 | Paranasal Sinus Neoplasms | 3.5% |
| 223 | Leukoplakia | 3.4% |
| 224 | Lymphocele | 3.4% |
| 225 | Pancreatic Cyst | 3.4% |
| 226 | Lung Neoplasms | 3.4% |
| 227 | Pleural Neoplasms | 3.4% |
| 228 | Barrett Esophagus | 3.4% |
| 229 | Breast Cyst | 3.4% |
| 230 | Histiocytic Disorders, Malignant | 3.4% |
| 231 | Actinic keratosis | 3.4% |
| 232 | Mediastinal Cyst | 3.4% |
| 233 | Neoplasm Invasiveness | 3.4% |
| 234 | Neoplasm Metastasis | 3.4% |
| 235 | Neoplasm Recurrence, Local | 3.4% |
| 236 | Parovarian Cyst | 3.4% |
| 237 | Pericardial Cyst | 3.4% |
| 238 | Thymic Cyst | 3.4% |
| 239 | Carcinogenesis | 3.4% |
| 240 | Myxoid cyst | 3.4% |
| 241 | Metastasis | 3.4% |
| 242 | Lambert-Eaton Myasthenic Syndrome | 3.3% |
| 243 | Brain Neoplasms | 3.3% |
| 244 | Spinal Cord Neoplasms | 3.3% |
| 245 | Carcinosarcoma | 3.3% |
| 246 | Hemangiosarcoma | 3.3% |
| 247 | Leukemia L1210 | 3.3% |
| 248 | Leukemia P388 | 3.3% |
| 249 | lymphangiosarcoma | 3.3% |
| 250 | Prolactinoma | 3.3% |
| 251 | Growth Hormone-Secreting Pituitary Adenoma | 3.3% |
| 252 | melanoma | 3.3% |
| 253 | Uterine Neoplasms | 3.3% |
| 254 | Vaginal Neoplasms | 3.3% |
| 255 | Vulvar Neoplasms | 3.3% |
| 256 | Uterine Cancer | 3.3% |
| 257 | Fallopian Tube Neoplasms | 3.3% |
| 258 | Leydig Cell Tumor | 3.1% |
| 259 | Lymphomatoid Granulomatosis | 3% |
| 260 | Optic Nerve Glioma | 3% |
| 261 | Choriocarcinoma | 3% |
| 262 | Opsoclonus-Myoclonus Syndrome | 3% |
| 263 | Sarcoma 180 | 3% |
| 264 | Meningeal Carcinomatosis | 2.9% |
| 265 | granulosa cell tumor | 2.9% |
| 266 | Carcinoma, Ovarian Epithelial | 2.9% |
| 267 | Central Nervous System Cysts | 2.9% |
| 268 | Medulloblastoma | 2.8% |
| 269 | Maxillary Sinus Neoplasms | 2.8% |
| 270 | Bile Duct Neoplasms | 2.8% |
| 271 | gallbladder neoplasm | 2.8% |
| 272 | Intestinal Neoplasms | 2.8% |
| 273 | Penile Neoplasms | 2.8% |
| 274 | Prostatic Neoplasms | 2.8% |
| 275 | Stomach Neoplasms | 2.8% |
| 276 | Composite Lymphoma | 2.8% |
| 277 | Lymphoma | 2.8% |
| 278 | Peritonsillar Abscess | 2.8% |
| 279 | Polycythemia Vera | 2.8% |
| 280 | Adenomatous Polyposis Coli | 2.8% |
| 281 | Corpus Luteum Cyst | 2.8% |
| 282 | Ovarian Cysts | 2.8% |
| 283 | Leukemia, Plasma Cell | 2.7% |
| 284 | Adenoma, Acidophil | 2.7% |
| 285 | Ganglioneuroma | 2.7% |
| 286 | Glioma | 2.7% |
| 287 | Mesoblastic Nephroma | 2.7% |
| 288 | Malignant Glioma | 2.7% |
| 289 | Myelitis, Transverse | 2.7% |
| 290 | Basal cell carcinoma | 2.6% |
| 291 | Carcinoma, Papillary | 2.6% |
| 292 | Squamous cell carcinoma | 2.6% |
| 293 | Chondrosarcoma | 2.6% |
| 294 | Craniopharyngioma | 2.6% |
| 295 | Cystadenoma | 2.6% |
| 296 | leiomyosarcoma | 2.6% |
| 297 | liposarcoma | 2.6% |
| 298 | Mesothelioma | 2.6% |
| 299 | synovial sarcoma | 2.6% |
| 300 | Neuroectodermal Tumor, Melanotic | 2.6% |
| 301 | Angiomyolipoma | 2.6% |
| 302 | Clear Cell Sarcoma of Soft Tissue | 2.6% |
| 303 | Alveolar Soft Part Sarcoma | 2.6% |
| 304 | Neuroendocrine Tumors | 2.6% |
| 305 | Sarcoma, Myeloid | 2.6% |
| 306 | Carcinoma, Basal Cell | 2.6% |
| 307 | Bronchial Neoplasms | 2.5% |
| 308 | Adenoma | 2.5% |
| 309 | Ameloblastoma | 2.5% |
| 310 | Angiokeratoma | 2.5% |
| 311 | Carcinoma | 2.5% |
| 312 | Chordoma | 2.5% |
| 313 | Hemangioma | 2.5% |
| 314 | hemangiopericytoma | 2.5% |
| 315 | Lymphangioma | 2.5% |
| 316 | Mesenchymoma | 2.5% |
| 317 | Nevus | 2.5% |
| 318 | Teratoma | 2.5% |
| 319 | Hepatoblastoma | 2.5% |
| 320 | Mixed Tumor, Mullerian | 2.5% |
| 321 | Germinoma | 2.5% |
| 322 | Teratocarcinoma | 2.5% |
| 323 | Angiofibroma | 2.5% |
| 324 | Sarcoma | 2.5% |
| 325 | Epithelioma | 2.5% |
| 326 | Multiple Pulmonary Nodules | 2.5% |
| 327 | Bladder Neoplasm | 2.5% |
| 328 | Kidney Neoplasm | 2.5% |
| 329 | Ureteral Neoplasms | 2.5% |
| 330 | Urethral Neoplasms | 2.5% |
| 331 | Supratentorial Neoplasms | 2.4% |
| 332 | Adrenocortical carcinoma | 2.4% |
| 333 | Carcinoid Tumor | 2.4% |
| 334 | Endometrial Neoplasms | 2.4% |
| 335 | Neurilemmoma | 2.4% |
| 336 | Hutchinson's Melanotic Freckle | 2.4% |
| 337 | Melanoma, Amelanotic | 2.4% |
| 338 | Choledochal Cyst | 2.4% |
| 339 | Peutz-Jeghers Syndrome | 2.4% |
| 340 | Cystadenocarcinoma | 2.3% |
| 341 | Fibrosarcoma | 2.3% |
| 342 | Osteosarcoma | 2.3% |
| 343 | Mucoepidermoid Carcinoma | 2.3% |
| 344 | Astrocytoma | 2.2% |
| 345 | Renal Cell Carcinoma | 2.2% |
| 346 | Ependymoma | 2.2% |
| 347 | oligodendroglioma | 2.2% |
| 348 | Ganglioglioma | 2.2% |
| 349 | gliosarcoma | 2.2% |
| 350 | Anaplastic astrocytoma | 2.2% |
| 351 | Anaplastic Oligodendroglioma | 2.2% |
| 352 | Papillary Renal Cell Carcinoma | 2.2% |
| 353 | Pleural Effusion, Malignant | 2.1% |
| 354 | Adenofibroma | 2.1% |
| 355 | Fibroadenoma | 2.1% |
| 356 | Malignant Fibrous Histiocytoma | 2.1% |
| 357 | Prostatic Neoplasms, Castration-Resistant | 2.1% |
| 358 | Endometrial Stromal Sarcoma | 2.1% |
| 359 | Nelson Syndrome | 2.1% |
| 360 | Brain Stem Neoplasms | 2% |
| 361 | Malignant Carcinoid Syndrome | 2% |
| 362 | Pancreatic Pseudocyst | 2% |
| 363 | Plasmacytoma | 2% |
| 364 | Malignant histiocytosis | 2% |
| 365 | Lymphatic Metastasis | 2% |
| 366 | Neoplasms, Unknown Primary | 2% |
| 367 | Leukemic Infiltration | 2% |
| 368 | Histiocytic sarcoma | 2% |
| 369 | Neoplasm Micrometastasis | 2% |
| 370 | Bowen's Disease | 1.9% |
| 371 | Paraganglioma | 1.9% |
| 372 | Rhabdomyosarcoma | 1.9% |
| 373 | Giant Cell Tumor of Bone | 1.9% |
| 374 | Hydatidiform Mole | 1.9% |
| 375 | Glioblastoma | 1.9% |
| 376 | Neuroblastoma | 1.9% |
| 377 | Denys-Drash Syndrome | 1.9% |
| 378 | Glioblastoma Multiforme | 1.9% |
| 379 | Carcinoma, Endometrioid | 1.9% |
| 380 | Lymphangioleiomyomatosis | 1.9% |
| 381 | Cecal Neoplasms | 1.8% |
| 382 | Duodenal Neoplasms | 1.8% |
| 383 | Choroid Plexus Papilloma | 1.8% |
| 384 | Dermatofibrosarcoma | 1.8% |
| 385 | Dermatofibrosarcoma Protuberans | 1.8% |
| 386 | Ganglioneuroblastoma | 1.7% |
| 387 | Cerebellar Neoplasms | 1.7% |
| 388 | Neurofibrosarcoma | 1.7% |
| 389 | Adenocarcinoma | 1.6% |
| 390 | Carcinoma in Situ | 1.6% |
| 391 | Carcinoma, Transitional Cell | 1.6% |
| 392 | Phyllodes Tumor | 1.6% |
| 393 | Dysgerminoma | 1.6% |
| 394 | Hemangioendothelioma | 1.6% |
| 395 | Hodgkin Disease | 1.6% |
| 396 | Lipoma | 1.6% |
| 397 | Lymphoma, Non-Hodgkin | 1.6% |
| 398 | Myoma | 1.6% |
| 399 | Myxoma | 1.6% |
| 400 | Neuroma | 1.6% |
| 401 | Papilloma | 1.6% |
| 402 | Pseudomyxoma Peritonei | 1.6% |
| 403 | Seminoma | 1.6% |
| 404 | Papillomatosis | 1.6% |
| 405 | Angiolipoma | 1.6% |
| 406 | Myelolipoma | 1.6% |
| 407 | Neoplasms, Bone Tissue | 1.6% |
| 408 | Neoplasms, Fibrous Tissue | 1.6% |
| 409 | Smooth Muscle Tumor | 1.6% |
| 410 | Adenomatosis, Pulmonary | 1.6% |
| 411 | Adenomatous Polyps | 1.6% |
| 412 | Carcinoma, Large Cell | 1.6% |
| 413 | Carcinoma, Small Cell | 1.6% |
| 414 | Desmoplastic Small Round Cell Tumor | 1.6% |
| 415 | Chondroma | 1.6% |
| 416 | Enchondroma | 1.6% |
| 417 | Polycystic Ovary Syndrome | 1.6% |
| 418 | Colorectal Neoplasms | 1.6% |
| 419 | Pheochromocytoma | 1.6% |
| 420 | Alveolar rhabdomyosarcoma | 1.6% |
| 421 | Carcinoid Heart Disease | 1.6% |
| 422 | Xeroderma Pigmentosum | 1.5% |
| 423 | Appendiceal Neoplasms | 1.5% |
| 424 | Colonic Neoplasms | 1.5% |
| 425 | Rectal Neoplasms | 1.5% |
| 426 | Primary amyloidosis | 1.4% |
| 427 | Leukemia, Myelomonocytic, Chronic | 1.3% |
| 428 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1.3% |
| 429 | Adenoid Cystic Carcinoma | 1.2% |
| 430 | fibroma | 1.2% |
| 431 | Fibromatosis | 1.2% |
| 432 | Osteoblastoma | 1.2% |
| 433 | Osteoma | 1.2% |
| 434 | Rhabdomyoma | 1.2% |
| 435 | Chondromatosis | 1.2% |
| 436 | Adenocarcinoma, Clear Cell | 1.2% |
| 437 | Cholangiocarcinoma | 1.2% |
| 438 | Cervical Intraepithelial Neoplasia | 1.2% |
| 439 | Hemangioblastoma | 1.2% |
| 440 | Lymphoma, Extranodal NK-T-Cell | 1.2% |
| 441 | Anus Neoplasms | 1.2% |
| 442 | Sigmoid Neoplasms | 1.2% |
| 443 | Mastocytosis | 1.1% |
| 444 | Sturge-Weber Syndrome | 1.1% |
| 445 | Cell Transformation, Viral | 1.1% |
| 446 | Waldenstrom Macroglobulinemia | 1.1% |
| 447 | Multiple Myeloma | 1.1% |
| 448 | Gastrointestinal Stromal Tumors | 1.1% |
| 449 | Hemangioma, Cavernous | 1.1% |
| 450 | Leukemia, T-Cell | 1.1% |
| 451 | Leukemia, B-Cell | 1.1% |
| 452 | neurofibroma | 1.1% |
| 453 | Lymphoma, Follicular | 1.1% |
| 454 | T-Cell Lymphoma | 1.1% |
| 455 | Mantle cell lymphoma | 1.1% |
| 456 | Fibromatosis, Aggressive | 1% |
| 457 | Fibromatosis, Abdominal | 1% |
| 458 | Klatskin Tumor | 1% |
| 459 | Zollinger-Ellison syndrome | 1% |
| 460 | Mastocytoma | 1% |
| 461 | Mastocytosis, Systemic | 1% |
| 462 | Leukemia, Myeloid, Chronic-Phase | 1% |
| 463 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 464 | Leukemia, Large Granular Lymphocytic | 0.8% |
| 465 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.8% |
| 466 | Lymphoma, T-Cell, Cutaneous | 0.8% |
| 467 | Lymphoma, AIDS-Related | 0.8% |
| 468 | Enteropathy-Associated T-Cell Lymphoma | 0.8% |
| 469 | Primary Effusion Lymphoma | 0.8% |
| 470 | Dupuytren Contracture | 0.7% |
| 471 | Urticaria Pigmentosa | 0.7% |
| 472 | Mycosis Fungoides | 0.7% |
| 473 | Lymphomatoid Papulosis | 0.7% |
| 474 | Plasmablastic lymphoma | 0.7% |
| 475 | Burkitt Lymphoma | 0.6% |
| 476 | Sezary Syndrome | 0.5% |